Predictors of Mortality Within 90 Days of Cataract Surgery
Overview
Authors
Affiliations
Purpose: To identify predictors of mortality within 90 days of cataract surgery.
Design: A retrospective cohort study.
Participants: A total of 45,082 patients who underwent cataract surgery in the Veterans Health Administration (VHA) between October 1, 2005 and September 30, 2007.
Methods: The National Patient (US) Care Database (NPCD) was used to identify all patients who underwent outpatient extracapsular cataract surgery performed in the VHA and who had only 1 cataract surgery within 90 days of the index surgery. Data collected includes demographics, number of hospitalizations within 1 year before surgery, postoperative mortality, and systemic comorbidities using the Charlson Comorbidity Index (CCI), which predicts the 1-year mortality for a patient based on a range of co-morbid conditions scored 1, 2, 3 or 6 depending on the risk of dying associated with the condition. Adjusted odds ratios (OR) of factors predictive of 90-day mortality were calculated using logistical regression modeling.
Main Outcome Measures: Mortality within 90 days of cataract surgery.
Results: Of the 53,786 patients who underwent cataract surgery during the study period, 45,082 met inclusion criteria. Mean age was 71.8 years; 97.6% were men; 5.0% had complex cataract surgery. The most frequent systemic comorbidities in the CCI were diabetes mellitus (40.6%), chronic pulmonary disease (21.2%), malignant neoplasms (12.5%) and congestive heart failure (CHF; 9.5%). Patients had a median CCI score of 1; 43.7% had a score ≥ 2. Mortality rate within 90 days after cataract surgery was 7.1 per 1000 patients. Independent predictors of 90-day postoperative mortality were [adjusted OR, (95% confidence interval; CI)]: age 80 or greater [2.54 (1.62, 3.98)], CCI ≥ 2 [2.06 (1.58, 2.70)], ≥ 1 hospitalizations in the past year [1.85 (1.45, 2.36)], chronic pulmonary disease (CPD) [1.69 (1.34, 2.14)], CHF [1.71 (1.29, 2.14)], cirrhosis [2.60 (1.31, 5.15)], multiple myeloma or leukemia [2.20 (1.07, 4.53)], and metastatic solid tumor [4.17 (1.80, 9.66)].
Conclusions: The risk of 90-day mortality after cataract surgery is low, even for patients at higher risk for mortality such as the elderly and those with a high preoperative disease burden.
Life-threatening complications in ophthalmic surgery: a systematic review.
Ferrara M, Romano V, Longo L, Rovati M, Raimondi R, Semeraro F Eye (Lond). 2024; 39(1):69-78.
PMID: 39580602 PMC: 11733002. DOI: 10.1038/s41433-024-03442-1.
Shoraibi M, Masoudifar M, Shetabi H Adv Biomed Res. 2024; 13:81.
PMID: 39512415 PMC: 11542690. DOI: 10.4103/abr.abr_321_23.
Evaluation of choosing wisely recommendations on preprocedural cardiovascular testing.
Patel K, Winchester D Am Heart J Plus. 2024; 13:100107.
PMID: 38560075 PMC: 10978204. DOI: 10.1016/j.ahjo.2022.100107.
Lee H, Hwang S, Park C, Chung S, Chen C, Lee J Epidemiol Health. 2024; 46:e2024015.
PMID: 38228088 PMC: 11099570. DOI: 10.4178/epih.e2024015.
Idiopathic Epiretinal Membrane Surgery in Patients Aged Over 80 Years: Efficacy and Safety.
Li Q, Yang K, Ji Q, Jiang J, Zong R, Zhang Y Clin Ophthalmol. 2023; 17:3365-3372.
PMID: 37941775 PMC: 10629405. DOI: 10.2147/OPTH.S437815.